ARWR   $20.5  -3.21% Market Closed After Close 20.49 -0.05%

Arrowhead Pharmaceuticals Inc
Total Cash 434.47M
totalCashPerShare 3.495
EBITDA -529.78M
Total Debt 454.12M
quickRatio 4.492
currentRatio 4.654
Total Revenue 19.65M
debtToEquity 133.97
Revenue/Share 0.17
ROA -0.40724
ROE -1.51843
grossProfits
freeCashflow -413.91M
operatingCashflow -351.56M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -27.85052
profitMargins 0.0
enterpriseValue 2.66B
forwardPE -4.8554506
floatShares 110.49M
sharesOutstanding 124.31M
sharesShort 8.92M
sharesShortPriorMonth 8.65M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.81%
Short Ratio help_outline 7.50%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 2.661
Price To Book help_outline 7.70
earningsQuarterlyGrowth
netIncomeToCommon -538.64M
trailingEps -4.65%
forwardEps -4.22%
enterpriseToEbitda -5.02
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.05 3Q 2024
institutionsCount 367
lastUpdated Oct. 22, 2024, 3:23 a.m.